{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:12:50Z","timestamp":1793718770325,"version":"4.6.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Benefit from chemotherapy for well-differentiated\/de-differentiated (WD\/DD) liposarcomas has been reported to be minimal, however traditional response criteria may not adequately capture positive treatment effect. In this study, we evaluate benefit from first-line chemotherapy and characterize imaging response characteristics in patients with retroperitoneal (RP) WD\/DD liposarcoma treated at The University of Texas MD Anderson Cancer Center. Response was assessed using RECIST (Response Evaluation Criteria in Solid Tumors) and an exploratory analysis of vascular response was characterized. Among 82 patients evaluable for response to first-line therapy, 31 patients received neoadjuvant chemotherapy for localized\/locally advanced disease; 51 received chemotherapy for unresectable recurrent\/metastatic disease. Median overall survival from the start of chemotherapy was 29 months (95% CI 24\u201340 months). Response rates by RECIST: partial response (PR) 21% (17\/82), stable disease (SD) 40%, and progression (PD) 39%. All RECIST responses were in patients receiving combination chemotherapy. A qualitative vascular response was seen in 24 patients (31%). Combination chemotherapy yields a response rate of 24% and a clinical benefit rate (CR\/PR\/SD\u2009&gt;\u20096 months) of 44%, higher than previously reported in DD liposarcoma. A higher percentage of patients experience a vascular response with chemotherapy that is not adequately captured by RECIST in these large heterogeneous tumors.<\/jats:p>","DOI":"10.1038\/s41598-017-12132-w","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:02:47Z","timestamp":1505293367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-3282","authenticated-orcid":false,"given":"J. A.","family":"Livingston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5284-1555","authenticated-orcid":false,"given":"D.","family":"Bugano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Madewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. W.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. L.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. W.","family":"Feig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Somaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"12132_CR1","doi-asserted-by":"crossref","unstructured":"Raut, C. P. et al. External validation of a multi\u2010institutional retroperitoneal sarcoma nomogram. Cancer (2016).","DOI":"10.1002\/cncr.29931"},{"key":"12132_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/dc.21794","volume":"40","author":"LG Dodd","year":"2012","unstructured":"Dodd, L. G. Update on liposarcoma: a review for cytopathologists. Diagnostic cytopathology \n                           40, 1122\u20131131 (2012).","journal-title":"Diagnostic cytopathology"},{"key":"12132_CR3","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000086542.11899.38","volume":"238","author":"S Singer","year":"2003","unstructured":"Singer, S., Antonescu, C. R., Riedel, E. & Brennan, M. F. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Annals of surgery \n                           238, 358 (2003).","journal-title":"Annals of surgery"},{"key":"12132_CR4","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/annonc\/mdr485","volume":"23","author":"A Italiano","year":"2012","unstructured":"Italiano, A. et al. Advanced well-differentiated\/dedifferentiated liposarcomas: role of chemotherapy and survival. Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO \n                           23, 1601\u20131607, https:\/\/doi.org\/10.1093\/annonc\/mdr485 (2012).","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO"},{"key":"12132_CR5","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.ejca.2005.07.023","volume":"41","author":"RL Jones","year":"2005","unstructured":"Jones, R. L., Fisher, C., Al-Muderis, O. & Judson, I. R. Differential sensitivity of liposarcoma subtypes to chemotherapy. European journal of cancer \n                           41, 2853\u20132860, https:\/\/doi.org\/10.1016\/j.ejca.2005.07.023 (2005).","journal-title":"European journal of cancer"},{"key":"12132_CR6","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1470-2045(12)70474-6","volume":"13","author":"I Ray-Coquard","year":"2012","unstructured":"Ray-Coquard, I. et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. The lancet oncology \n                           13, 1133\u20131140 (2012).","journal-title":"The lancet oncology"},{"key":"12132_CR7","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1200\/JCO.2012.46.5476","volume":"31","author":"MA Dickson","year":"2013","unstructured":"Dickson, M. A. et al. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Journal of Clinical Oncology \n                           31, 2024\u20132028 (2013).","journal-title":"Journal of Clinical Oncology"},{"key":"12132_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1634\/theoncologist.13-S2-32","volume":"13","author":"SM Schuetze","year":"2008","unstructured":"Schuetze, S. M., Baker, L. H., Benjamin, R. S. & Canetta, R. Selection of response criteria for clinical trials of sarcoma treatment. The Oncologist \n                           13, 32\u201340 (2008).","journal-title":"The Oncologist"},{"key":"12132_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1148\/radiol.2512081403","volume":"251","author":"S Stacchiotti","year":"2009","unstructured":"Stacchiotti, S. et al. High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment\u2014Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria 1. Radiology \n                           251, 447\u2013456 (2009).","journal-title":"Radiology"},{"key":"12132_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/RCT.0000000000000462","volume":"40","author":"P Bhosale","year":"2016","unstructured":"Bhosale, P. et al. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma? Journal of Computer Assisted Tomography \n                           40, 872\u2013879 (2016).","journal-title":"Journal of Computer Assisted Tomography"},{"key":"12132_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.6004\/jnccn.2014.0053","volume":"12","author":"M von Mehren","year":"2014","unstructured":"von Mehren, M. et al. Soft tissue sarcoma, version 2.2014. Journal of the National Comprehensive Cancer Network \n                           12, 473\u2013483 (2014).","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"12132_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","volume":"15","author":"I Judson","year":"2014","unstructured":"Judson, I. et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. The lancet oncology \n                           15, 415\u2013423 (2014).","journal-title":"The lancet oncology"},{"key":"12132_CR13","unstructured":"Somaiah, N. et al. In Connective Tissue Oncology Society (CTOS) Annual Meeting (Salt Lake City, UT, 2015)."},{"key":"12132_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/cncr.28657","volume":"120","author":"LA Doyle","year":"2014","unstructured":"Doyle, L. A. Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone. Cancer \n                           120, 1763\u20131774 (2014).","journal-title":"Cancer"},{"key":"12132_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). European journal of cancer \n                           45, 228\u2013247 (2009).","journal-title":"European journal of cancer"},{"key":"12132_CR16","unstructured":"Woolson, R. F. & Clarke, W. R. Statistical methods for the analysis of biomedical data. Vol. 371 (John Wiley & Sons, 2011)."},{"key":"12132_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen, J. A coefficient of agreement for nominal scales. Educational and psychological measurement \n                           20, 37\u201346 (1960).","journal-title":"Educational and psychological measurement"},{"key":"12132_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. Nonparametric estimation from incomplete observations. Journal of the American statistical association \n                           53, 457\u2013481 (1958).","journal-title":"Journal of the American statistical association"},{"key":"12132_CR19","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer chemotherapy reports. Part 1 \n                           50, 163\u2013170 (1966).","journal-title":"Cancer chemotherapy reports. Part 1"},{"key":"12132_CR20","doi-asserted-by":"crossref","unstructured":"Cox, D. R. Regression models and life-tables. Journal of the Royal Statistical Society. Series B (Methodological), 187\u2013220 (1972).","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12132-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12132-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:04:01Z","timestamp":1671793441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12132-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12132-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"assertion":[{"value":"30 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11836"}}